Colorado BioScience Association Names Steve Orndorff Board Chair and Appoints Four New Board Members at 2011 Annual All-Member Meeting

DENVER--()--Steve Orndorff, Ph.D., CEO of Ariel Pharmaceuticals (, was named chairperson of the board of directors for the Colorado BioScience Association (CBSA) at its 2011 Annual All-Member meeting held at the Colorado National Golf Club facilities in Erie, CO, yesterday. The announcement is made by Holli Baumunk, CBSA President & CEO, who says Orndorff assumes chairperson responsibilities from Rick Jory, CEO of Sandhill Scientific, Highlands Ranch (

Dr. Orndorff, a serial entrepreneur with 30 years experience in the biotechnology industry, leads Ariel Pharmaceuticals, a startup specialty pharmaceutical company focused on orphan diseases and acute medical conditions of neurological origin. He is also the former founder, President and CEO of Accera, Inc. and President and CEO of Univera Pharmaceuticals, Inc., a drug discovery company focused on diseases of inflammation and the immune response.

During his career, Dr. Orndorff has had responsibility in a broad array of disciplines such as basic research, manufacturing, product development and business development at various biotechnology companies including Genex Corporation, NutraSweet, Inc. and ZeaGen, Inc. He is a past President of the Society for Industrial Microbiology and a founding board member of the CBSA. He received a Bachelor’s Degree in Biology from Virginia Tech and a Ph.D. in microbiology from the University of Maryland.

Joining Dr. Orndorff on the CBSA Board officer team will be newly appointed vice chairperson Derek Cole, Vice President, Investor Relations, ARCA biopharma ( Treasurer Norwood Robb, Denver School of Science and Technology (, and Secretary Linda Pryor, Pfizer, Inc. (, will both be continuing as officers. In other action, four new board members were approved by the CBSA membership.

Newly appointed CBSA board members include:

Reappointments of CBSA board members include:

The CBSA’s 2011 association sponsors include:



Boettcher Foundation -

Colorado Science + Technology Park at Fitzsimons -

Colorado State University -

Johnson & Johnson -



Colorado Office of Economic Development and International Trade -

University of Colorado -

Cooley -

Ernst & Young -

Merck -

Metro Denver Economic Development Corporation -

Polsinelli Shughart -




Amgen -

Dorsey & Whitney -

LABS Inc. -

Pfizer -

Snell & Wilmer -



CaridianBCT -

Faegre & Benson -

Holland & Hart -

Roche Colorado -

Southeast Business Partnership -



Baxa -

Corporex -

EideBailly -

Fairfield and Woods -

SomaLogic -



About the Colorado Bioscience Association

The CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 350 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. For more information, visit

CBSA also is found on these social media sites:
LinkedIn Group:
Facebook Fan Page:
YouTube Channel:


Colorado BioScience Association
Mae Desaire, 720-382-5918
Director of Marketing
Absolutely PR
Maggie Chamberlin Holben, APR, 303-984-9801

Release Summary

Colorado BioScience Association (CBSA) announces Steve Orndorff, President & CEO of Ariel pharmaceuticals, as the new chairperson of the board of directors.


Colorado BioScience Association
Mae Desaire, 720-382-5918
Director of Marketing
Absolutely PR
Maggie Chamberlin Holben, APR, 303-984-9801